Viewing Study NCT06587412



Ignite Creation Date: 2024-10-26 @ 3:39 PM
Last Modification Date: 2024-10-26 @ 3:39 PM
Study NCT ID: NCT06587412
Status: NOT_YET_RECRUITING
Last Update Posted: None
First Post: 2024-09-04

Brief Title: Treatment of Lateral Epicondylalgia With Shock Waves
Sponsor: None
Organization: None

Study Overview

Official Title: Radial Shock Waves Versus Focal Shock Waves in the Treatment of Lateral Epicondylalgia
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Lateral epicondylalgia LET is characterized by pain decreased muscle strength of the wrist extensor muscles and disability Among the treatments proposed in the literature both focal shockwave therapy and radial shockwave therapy have been considered effective in the management of this musculoskeletal disorder The objective of this study is to compare the safety and effectiveness of these two shockwave applications on the signs and symptoms of subjects with lateral epicondylalgia In this clinical trial subjects will be evaluated for elbow pain using a Visual Analog Scale VAS grip strength using a handheld dynamometer and degree of disability using the Patient-Rated Tennis Elbow Evaluation Questionnaire PRTEE A six-month follow-up will be performed

Patients will be randomly divided into three groups The first group will receive radial shock waves rESWT the second group will receive focal shock waves fESWT and the third group which will act as a control will receive a placebo treatment with very low energy parameters according to the literature

Subjects will receive three sessions one session per week
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None